Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy

Hongying Sui, Caixia Shi, Zhiping Yan, Hucheng Li
  • Drug Design Development and Therapy, June 2015, Dove Medical Press
  • DOI: 10.2147/dddt.s82035

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

The following have contributed to this page: Dr Hongying Sui

In partnership with: